Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Recruiting 3Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 16Glioblastoma 8Ovarian Neoplasms 7Colonic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 6Pancreatic Neoplasms 5Rectal Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Neoplasms 2Melanoma 2Liver Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Rectal Cancer Patients 1Prostatic Neoplasms 1Platinum-Refractory Fallopian Tube Carcinoma 1Peritoneal Neoplasms 1Optic Nerve Diseases 1

Interventions

Etoposide 6Radiotherapy 4Cisplatin 3Docetaxel 2Carboplatin 2venetoclax 1trametinib 1toripalimab 1tislelizumab 1talazoparib 1sacituzumab govitecan 1rovalpituzumab tesirine 1regorafenib 1poly ICLC 1pembrolizumab 1olaparib 1obatoclax 1nintedanib 1fludarabine phosphate 1etoposide phosphate 1enoxaparin sodium 1durvalumab 1alpha-Tocopherol 1Vitamin E 1Topotecan 1Tomography, Optical Coherence 1Thymalfasin 1Taxes 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Small Cell Lung Carcinoma × Bevacizumab × Clear all
NCT00755157 2015-10-07

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

University Hospital of Crete

Phase 2 Withdrawn
Thoracic

Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡